Some studies addressing chronic myeloid leukemia (CML) LSCs demonstrated that differentially expressed antigens include CD25, CD26, IL-1RAP, which is associated with the activation of NF-kβ and AKT signaling pathways, increasing proliferation of CML LSCs. Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.